CGEN (Compugen) יחס שווי שוק לשווי בספרים

Compugen Ltd. (CGEN) focuses on developing advanced antibodies to combat tumors, receiving financial support from pharmaceutical behemoths. This price chart reflects current market quotes, where the indicator stands at 2.01. The business model relies on the full outsourcing of production and testing, allowing the scientific team to minimize capital expenditures and maintain operational flexibility.

For Compugen Ltd. (CGEN), whose revenues depend on licensing payments in the absence of its own commercial product, this metric defines the gap between the actual value of net assets and speculative market expectations regarding research success. By analyzing the market-to-book ratio, an investor assesses the relationship between the current market price and the book value, which allows for the identification of business overvaluation and the risk of a sharp capital correction.